Financials

  • Market Capitalization 12.54 B
  • Employee 4 700
  • Founded 2004
  • CEO Adam Elsesser
  • Website www.penumbrainc.com
  • Headquarter Delaware, United States
  • FIGI BBG001BP92V1
  • Industry Medical Devices
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
68.79
Price to sales ratio
8.7

Related tickers

#NamePrice24h %7d %1M %1Y %Market CapLast 7 Days
621
ZBH
Zimmer Biomet Holdings, Inc. Common Stock
94.09 USD+2.99%+3.98%+6.00%-9.09%18.20 B USD
749
SNN
Smith & Nephew SNATS Inc
31.08 USD+1.24%+0.55%+1.30%-15.20%13.64 B USD
855
PODD
Insulet Corporation - Common Stock
162.06 USD+0.48%-1.08%+8.60%-44.68%11.23 B USD
873
GMED
Globus Medical, Inc. Class A Common Stock
79.72 USD+2.05%-2.05%+1.13%+37.73%10.82 B USD

Frequently asked questions about Penumbra, Inc. Common Stock

What is the Penumbra, Inc. Common Stock stock price today?

The current price of Penumbra, Inc. Common Stock (PEN) is 318.94. Over the past 24 hours, the stock has changed by +0.26%. Follow the PEN chart for real-time price dynamics.

What is the stock ticker of Penumbra, Inc. Common Stock?

Penumbra, Inc. Common Stock trades under the ticker PEN. Tickers can differ by exchange, so always check the exchange and instrument details before trading.

Is Penumbra, Inc. Common Stock stock going up?

PEN has changed by -0.09% over the last week, -0.08% over the last month, and +22.67% over the last year. Review the chart to see whether the current move is part of a broader trend.

What was Penumbra, Inc. Common Stock net income for the last quarter?

Penumbra, Inc. Common Stock reported net income of 32.58 M for the last quarter. The previous quarter showed 47.34 M, which means net income changed by -31.17%.

How many employees does Penumbra, Inc. Common Stock have?

As of the latest available data, Penumbra, Inc. Common Stock has 4 700 employees. Workforce size can provide additional context about the company's scale and operations.

What is Penumbra, Inc. Common Stock EBITDA?

Penumbra, Inc. Common Stock EBITDA is 42.81 M, and its EBITDA margin is 11.42%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.

How can I buy Penumbra, Inc. Common Stock stock?

You can buy Penumbra, Inc. Common Stock (PEN) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.

Should I invest in Penumbra, Inc. Common Stock stock?

Investing in Penumbra, Inc. Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the PEN chart and related analysis on metatrader.com as part of your research.

Penumbra, Inc. Common Stock

Penumbra, Inc. is an American medical device company headquartered in Alameda, California. The company was founded by Arani Bose and Adam Elsesser in 2004. It manufactures devices for interventional therapies to treat vascular conditions such as stroke and aneurysm. In January 2026, Boston Scientific announced it would acquire Penumbra in a $15 billion cash and stock deal. The deal was expected to close by yearend.

News